文献速递临床免疫临床生化

不受载脂蛋白(a)异构体影响的脂蛋白(a)颗粒数检测方法

Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms.
PubMed 文献 · Clin Chim Acta · 2020-02-28

研究开发了一种夹心酶免疫分析法,以鼠单克隆抗载脂蛋白(a)抗体捕获、多克隆抗载脂蛋白B抗体检测,测定脂蛋白(a)颗粒数。该方法精密度好,检测限13 nmol/l,线性范围2-499 nmol/l,不受纤溶酶原和载脂蛋白B干扰,且无载脂蛋白(a)异构体偏倚。

要点

  • 新Lp(a)-P夹心酶免疫法测定颗粒数,不受apo(a)异构体影响。
  • 批内精密度5.5%-7.2%,总不精密度6.9%-12.1%,检测限13 nmol/l。
  • 线性范围2-499 nmol/l,纤溶酶原和apoB无干扰。

核心结论

  • Lp(a)-P检测法灵敏、精密、线性范围宽,适合关注apo(a)大小多态性导致不准确及免疫比浊法性能不佳的实验室。

研究设计与样本

  • 开发夹心酶免疫分析法,以鼠单克隆抗apo(a)抗体捕获、多克隆抗apoB抗体检测,并验证精密度、线性、检测限、干扰和apo(a)异构体偏倚。

主要发现

  • 批内精密度5.5%至7.2%,总不精密度6.9%至12.1%。
  • 检测限13 nmol/l,线性范围2至499 nmol/l。
  • 纤溶酶原至80 mg/dl和载脂蛋白B至200 mg/dl无干扰。
  • 偏倚图显示无与apo(a)大小(kringle 4 type 2重复数)相关的偏倚。

关键数值与推荐

  • 批内精密度5.5%至7.2%,总不精密度6.9%至12.1%。
  • 检测限13 nmol/l,线性范围2至499 nmol/l。
  • 纤溶酶原至80 mg/dl和载脂蛋白B至200 mg/dl无干扰。

临床怎么用

  • 对于关注apo(a)大小多态性导致Lp(a)测定不准确的实验室,可考虑采用Lp(a)-P颗粒数检测法作为替代。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lipoprotein(a) [Lp(a)] is an important cardiovascular risk factor, but clinical immunoassays are flawed. Apolipoprotein(a) [apo(a)], the characteristic protein of Lp(a), contains a variable number of kringle repeats (size isoforms) that make accurate measurement of Lp(a) difficult. We developed a sandwich enzyme immunoassay that uses a murine monoclonal anti-apo(a) antibody for capture and a polyclonal anti-apolipoprotein B (apo B) for detection. Because Lp(a) contains one molecule each of apo(a) and apo B, the assay measures the number of Lp(a) particles [Lp(a)-P] in the circulation without bias due to apo(a) size isoforms. METHODS: After developing and choosing the best anti-apo(a) clone for Lp(a) capture, we identified suitable reagents and ELISA conditions, and validated assay performance (precision, linearity, limit of detection, interferences, and apo(a) size isoform bias). RESULTS: The Lp(a)-P assay was precise with within-run precision of 5.5% to 7.2% and total imprecision of 6.9% to 12.1%. The assay had a limit of detection of 13 nmol/l and was linear from 2 to 499 nmol/l. There was no interference from plasminogen or apolipoprotein B up to 80 and 200 mg/dl, respectively, and bias plot showed no bias related to apo(a) size (kringle 4 type 2 repeats). CONCLUSIONS: Lp(a)-P assay is sensitive, precise and linear over a wide analytical range and is a suitable alternative for laboratories concerned about inaccuracy due to apo(a) size polymorphism and the poor performance of immunoturbidimetric assays.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Contois JH, Nguyen RA, Albert AL, et al. Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms. Clin Chim Acta. 2020. PMID: 32113814. doi:10.1016/j.cca.2020.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。